Search research articles
Contact Us
Filters
Showing results (301-310 of 398) with videos related to
Page
of 40
Sort By:
Experimental Hematology
|
January 30, 2007
Changes in salivary proteome following allogeneic hematopoietic stem cell transplantation
Matin M Imanguli, Jane C Atkinson, Kristen E Harvey, et al.
Neuron
|
May 15, 2012
The subtype of GluN2 C-terminal domain determines the response to excitotoxic insults
Marc-André Martel, Tomás J Ryan, Karen F S Bell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 11, 2009
Strategies to improve long-term outcome in stage IIIB inflammatory breast cancer: multimodality treatment including dose-intensive induction and high-dose chemotherapy
Claude Sportès, Seth M Steinberg, David J Liewehr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 8, 2012
Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignancies
Rachel B Salit, Daniel H Fowler, Wyndham H Wilson, et al.
The Journal of Experimental Medicine
|
May 12, 2017
PD-1 regulates KLRG1<sup>+</sup> group 2 innate lymphoid cells
Samuel Taylor, Yuefeng Huang, Grace Mallett, et al.
American Journal of Cancer Research
|
November 16, 2022
Targetable vulnerability of deregulated FOXM1/PLK1 signaling axis in diffuse large B cell lymphoma
Fang Yu, Hua He, Loretta J Nastoupil, et al.
Haematologica
|
May 2, 2016
Role of the tumor microenvironment in mature B-cell lymphoid malignancies
Nathan H Fowler, Chan Yoon Cheah, Randy D Gascoyne, et al.
Molecular Therapy. Methods & Clinical Development
|
February 23, 2023
Persistent hematopoietic polyclonality after lentivirus-mediated gene therapy for Fabry disease
Amr H Saleh, Michael Rothe, Dwayne L Barber, et al.
Eclinicalmedicine
|
August 20, 2024
Safety and activity of lenalidomide in combination with obinutuzumab in patients with relapsed indolent non-Hodgkin lymphoma: a single group, open-label, phase 1/2 trial
Ashwath Gurumurthi, Collin K Chin, Lei Feng, et al.
Science Translational Medicine
|
December 3, 2011
The PDL1-PD1 axis converts human TH1 cells into regulatory T cells
Shoba Amarnath, Courtney W Mangus, James C M Wang, et al.
Page
of 40
Search research articles
Search
Showing results (301-310 of 398) with videos related to
Sort By:
Page
of 40
Experimental Hematology
|
January 30, 2007
Changes in salivary proteome following allogeneic hematopoietic stem cell transplantation
Matin M Imanguli, Jane C Atkinson, Kristen E Harvey, et al.
Neuron
|
May 15, 2012
The subtype of GluN2 C-terminal domain determines the response to excitotoxic insults
Marc-André Martel, Tomás J Ryan, Karen F S Bell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 11, 2009
Strategies to improve long-term outcome in stage IIIB inflammatory breast cancer: multimodality treatment including dose-intensive induction and high-dose chemotherapy
Claude Sportès, Seth M Steinberg, David J Liewehr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 8, 2012
Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignancies
Rachel B Salit, Daniel H Fowler, Wyndham H Wilson, et al.
The Journal of Experimental Medicine
|
May 12, 2017
PD-1 regulates KLRG1<sup>+</sup> group 2 innate lymphoid cells
Samuel Taylor, Yuefeng Huang, Grace Mallett, et al.
American Journal of Cancer Research
|
November 16, 2022
Targetable vulnerability of deregulated FOXM1/PLK1 signaling axis in diffuse large B cell lymphoma
Fang Yu, Hua He, Loretta J Nastoupil, et al.
Haematologica
|
May 2, 2016
Role of the tumor microenvironment in mature B-cell lymphoid malignancies
Nathan H Fowler, Chan Yoon Cheah, Randy D Gascoyne, et al.
Molecular Therapy. Methods & Clinical Development
|
February 23, 2023
Persistent hematopoietic polyclonality after lentivirus-mediated gene therapy for Fabry disease
Amr H Saleh, Michael Rothe, Dwayne L Barber, et al.
Eclinicalmedicine
|
August 20, 2024
Safety and activity of lenalidomide in combination with obinutuzumab in patients with relapsed indolent non-Hodgkin lymphoma: a single group, open-label, phase 1/2 trial
Ashwath Gurumurthi, Collin K Chin, Lei Feng, et al.
Science Translational Medicine
|
December 3, 2011
The PDL1-PD1 axis converts human TH1 cells into regulatory T cells
Shoba Amarnath, Courtney W Mangus, James C M Wang, et al.
Page
of 40